Charles Schwab Corporation Preferred Stock, Shares Outstanding remained flat by 0.0% to 1.4M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.7%, from 1.4M to 1.4M. Over 5 years (FY 2020 to FY 2025), Preferred Stock, Shares Outstanding shows a downward trend with a -4.9% CAGR.
An increase indicates the issuance of new preferred equity, while a decrease signals share repurchases or conversions into common stock.
This metric quantifies the total number of preferred stock shares currently held by all shareholders, excluding treasury...
Most large-cap pharmaceutical companies have simplified capital structures, so this is often zero or very low compared to common share counts.
other_preferred_stock_shares_outstanding| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M |
| QoQ Change | — | +0.0% | -0.0% | +0.4% | +0.0% | -21.7% | -0.4% | -0.2% | -0.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -1.7% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.4% | -21.4% | -21.7% | -22.2% | -22.3% | -0.8% | -0.4% | -0.1% | +0.0% | +0.0% | +0.0% | +0.0% | -1.7% | -1.7% | -1.7% | -1.7% |